VEB-mononucleosis in children at the hospital stage in modern conditions
- 作者: Timchenko V.1, Bannova S.1, Pavlova N.1, Pavlova E.1, Kaplina T.1, Fedorova A.1, Bulina O.1, Balashov A.1, Hakizimana J.1
-
隶属关系:
- St. Petersburg State Pediatric Medical University
- 期: 卷 9, 编号 6 (2018)
- 页面: 77-82
- 栏目: Articles
- URL: https://journals.rcsi.science/pediatr/article/view/11228
- DOI: https://doi.org/10.17816/PED9677-82
- ID: 11228
如何引用文章
详细
VEB-mononucleosis is an actual infection of childhood. We analyzed 764 medical records of inpatients with VEB mononucleosis. Two groups of patients were formed: group I (young age) was 411 people (from 1 to 7 years), group II (school age) 353 people (from 7 to 17 years). In the I group, boys predominated, the peak of the disease occurred in the spring period, in group II – girls, the incidence of the incidence was noted in the winter. In both groups, moderate forms of the disease predominated, 684 people (89.5%). Severe forms of the disease prevailed in the children of group II. In group I the disease began acutely, and in the second group – subacute. In both groups, the whole syndrome of VEB mononucleosis was observed: fever, intoxication, acute tonsillitis, lymphadenopathy. The defeat of the nasopharynx and hepatosplenomegaly was more common in the I group. In this case, the increase in the size of the liver and spleen was up to 2 cm from the age norm. In the biochemical analysis of blood, an increase in ALT activity was detected with the same frequency in both age groups. Moreover, in the I group there was a moderate activity of ALT, in the II group – more significant. In clinical blood analysis, most patients in both age groups had leukocytosis. Lymphocytosis was more common in children of group I. Monocytosis was more common in children of group II. Increased ESR was observed in both groups with the same frequency. Atypical mononucleary in children of the I group appeared on the first, and in the older group – on the second week of the disease. A set of laboratory methods was used to diagnose VEB mononucleosis. In 100% of the observed children receiving viferon, there was a significant decrease in the duration of fever, intoxication, acute tonsillitis, lymphadenopathy, adenoiditis, hepatomegaly, splenomegaly and reduction in hospital stay.
作者简介
Vladimir Timchenko
St. Petersburg State Pediatric Medical University
编辑信件的主要联系方式.
Email: detinfection@mail.ru
MD, PhD, Dr Med Sci, Professor, Head, Department of Infectious Diseases in Children named after Prof. M.G. Danilevich
俄罗斯联邦, Saint PetersburgSvetlana Bannova
St. Petersburg State Pediatric Medical University
Email: detinfection@mail.ru
MD, PhD Associate Professor, Department of Infectious Diseases in Children named after Prof. M.G. Danilevich
俄罗斯联邦, Saint PetersburgNatalia Pavlova
St. Petersburg State Pediatric Medical University
Email: detinfection@mail.ru
MD, PhD Assistant Professor, Department of Infectious Diseases in Children named after Prof. M.G. Danilevich
俄罗斯联邦, Saint PetersburgElena Pavlova
St. Petersburg State Pediatric Medical University
Email: detinfection@mail.ru
MD, PhD Associate Professor, Department of Pharmacology
俄罗斯联邦, Saint PetersburgTatyana Kaplina
St. Petersburg State Pediatric Medical University
Email: detinfection@mail.ru
MD, PhD Associate Professor, Department of Infectious Diseases in Children named after Prof. M.G. Danilevich
俄罗斯联邦, Saint PetersburgAnna Fedorova
St. Petersburg State Pediatric Medical University
Email: detinfection@mail.ru
Assistant Professor, Department of Infectious Diseases in Children named after Prof. M.G. Danilevich
俄罗斯联邦, Saint PetersburgOksana Bulina
St. Petersburg State Pediatric Medical University
Email: detinfection@mail.ru
MD, PhD Associate Professor, Department of Rehabilitation AF and DPO
俄罗斯联邦, Saint PetersburgAlexey Balashov
St. Petersburg State Pediatric Medical University
Email: balashovAL7@yandex.ru
Associate Professor, Department of Propedeutics of Children's Diseases with a Course of General Care
俄罗斯联邦, Saint PetersburgJean-Claude Hakizimana
St. Petersburg State Pediatric Medical University
Email: detinfection@mail.ru
Postgraduate Student, Department of Infectious Diseases in Children named after Prof. M.G. Danilevich
俄罗斯联邦, Saint Petersburg参考
- Баннова С.Л. Сравнительная характеристика инфекционного мононуклеоза Эпштейна - Барр вирусной природы у детей дошкольного и школьного возраста // Ученые записки СПбГМУ им. акад. И.П. Павлова. - 2010. - Т. 17. - № 2. - С. 43-45. [Bannova SL. Comparative data on Epstein-Barr virus infectious mononucleosis in preschool and school age children. Scientific notes of the I.P. Pavlov St. Petersburg State Medical University. 2010;17(2):43-45. (In Russ.)]
- Исаков В.А. Герпесвирусные инфекции человека: руководство для врачей. - СПб.: СпецЛит, 2013. [Isakov VA. Gerpesvirusnye infektsii cheloveka: rukovodstvo dlya vrachey. Saint Petersburg: SpetsLit; 2013. (In Russ.)]
- Тимченко В.Н., Быстрякова Л.В., Павлова Е.Б., и др. Воздушно-капельные инфекции в практике педиатра и семейного врача: руководство для врачей всех специальностей. - СПб.: ЭЛБИ-СПб, 2007. [Timchenko VN, Bystryakova LV, Pavlova EB, et al. Vozdushno-kapel’nye infektsii v praktike pediatra i semeynogo vracha: rukovodstvo dlya vrachey vsekh spetsial’nostey. Saint Petersburg: ELBI-SPb; 2007. (In Russ.)]
- Тимченко В.Н., Баннова С.Л., Калинина Н.М., и др. Клиническая и иммунологическая эффективность рекомбинантного интерферона-альфа-2b при остром Эпштейна - Барр вирусном мононуклеозе у детей дошкольного возраста // Детские инфекции. - 2016. - Т. 15. - № 3. - С. 30-37. [Timchenko VN, Bannova SL, Kalinina NM, et al. Clinical and Immunological Efficacy of the Recombinant Interferon alfa-2b of Acute Epstein-Barr Viral Mononucleosis in Preschool Children. Detskie infektsii. 2016;15(3):30-37. (In Russ.)]
- Тимченко В.Н., Баннова С.Л., Федорова А.В., Назарова А.Н. Клинико-лабораторные критерии тяжести и принципы терапии острого инфекционного мононуклеоза Эпштейна - Барр вирусной этиологии у детей // Педиатр. - 2015. - Т. 6. - № 4. - С. 147-153. [Timchenko VN, Bannova SL, Fedorova AV, Nazarova AN. Clinical and laboratory criteria of gravity and the principles of treatment of acute infectious mononucleosis, Epstein-Barr virus etiology of the children. Pediatrician (St. Petersburg). 2015;6(4):147-153. (In Russ.)]. doi: 10.17816/PED64147-153.
- Тимченко В.Н., Хмилевская С.А. Болезни цивилизации (корь, ВЭБ-мононуклеоз) в практике педиатра: руководство для врачей. - СПб.: СпецЛит, 2017. [Timchenko VN, Khmilevskaya SA. Bolezni tsivilizatsii (kor’, VEB-mononukleoz) v praktike pediatra: rukovodstvo dlya vrachey. Saint Petersburg: SpetsLit; 2017. (In Russ.)]
- Хмилевская С.А., Зайцева И.А. Клинико-эпидемиологические аспекты инфекционного мононуклеоза у детей // Эпидемиология и вакцинация. - 2010. - № 5. - С. 45-50. [Khmilevskaya SA, Zaytseva IA. Clinical and Epidemiologic Aspects of Infectious Mononucleosis in Children. Epidemiol Vakcinoprofil. 2010;(5):45-50. (In Russ.)]
- Цинзерлинг А.В., Цинзерлинг В.А. Современные инфекции. Патологическая анатомия и вопросы патогенеза. Руководство. - СПб.: Sotis, 2002. [Tsinzerling AV, Tsinzerling VA. Sovremennye infektsii. Patologicheskaya anatomiya i voprosy patogeneza. Rukovodstvo. Saint Petersburg: Sotis; 2002. (In Russ.)]
- Ader F, Chatellier D, Le Berre R, et al. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject. Med Mal Infect. 2006;36(7):396-398. doi: 10.1016/j.medmal.2006.03.002.
- Okano M. Epstein-Barr virus infection and its role in the expanding spectrum of human diseases. Acta Paediatr. 2007;87(1):11-18. doi: 10.1111/j.1651-2227.1998.tb01377.x.
- Oertel SH, Riess H. Antiviral Treatment of Epstein-Barr Virus-Associated Lymphoproliferations. Recent Results in Cancer Research. 2002;159:89-95. doi: 10.1007/978-3-642-56352-2_11.
- Yuge A, Kinoshita E, Moriuchi M, et al. Persistent hepatitis associated with chronic active Epstein-Barr virus infection. Pediatr Infect Dis J. 2004;23(1):74-76. doi: 10.1097/01.inf.0000105182.51471.4b.